IL-27 regulates IL-18 binding protein in skin resident cells

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wittmann, Miriam ^a,b   Doble, Rosella ^c   Bachmann, Malte ^d   Pfeilschifter, Josef ^d   Werfel, Thomas ^e   Mühl, Heiko ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 27; MESSENGER RNA; STAT1 PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; IMMUNOMODULATION; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST;

BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FORESKIN; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKIN-18; KERATINOCYTES; LUCIFERASES; MALE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER;

EID: 84863006274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038751     Document Type: Article

References (66)

1. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, et al. (2004) WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172: 2225-2231.
2. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, et al. (2003) Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 170: 4886-4890.
3. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, et al. (2002) IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16: 779-790.
4. Lucas S, Ghilardi N, Li J, de Sauvage FJ, (2003) IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc Natl Acad Sci U S A 100: 15047-15052.
5. Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA, (2003) IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 23: 513-522.
6. Zeitvogel J, Werfel T, Wittmann M (submitted) IL-27 acts as a Priming Signal for IL-23 but not IL-12 production on human antigen presenting cells. submitted.
7. Wittmann M, Zeitvogel J, Wang D, Werfel T, (2009) IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J Allergy Clin Immunol 124: 81-89.
8. Shibata S, Tada Y, Kanda N, Nashiro K, Kamata M, et al. (2010) Possible roles of IL-27 in the pathogenesis of psoriasis. J Invest Dermatol 130: 1034-1039.
9. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, et al. (2006) Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945.
10. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, et al. (2006) Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177: 5377-5385.
11. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, et al. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929-936.
12. Sugiyama N, Nakashima H, Yoshimura T, Sadanaga A, Shimizu S, et al. (2008) Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann Rheum Dis 67: 1461-1467.
13. Kalliolias GD, Ivashkiv LB, (2008) IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J Immunol 180: 6325-6333.
14. Arend WP, Palmer G, Gabay C, (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223: 20-38.
15. McInnes IB, Liew FY, Gracie JA, (2005) Interleukin-18: a therapeutic target in rheumatoid arthritis? Arthritis Res Ther 7: 38-41.
16. Muhl H, Pfeilschifter J, (2004) Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur J Pharmacol 500: 63-71.
17. Wittmann M, Macdonald A, Renne J, (2009) IL-18 and skin inflammation. Autoimmun Rev 9: 45-48.
18. Akira S, (2000) The role of IL-18 in innate immunity. Curr Opin Immunol 12: 59-63.
19. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, et al. (1998) Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390.
20. Yamagata S, Tomita K, Sato R, Niwa A, Higashino H, et al. (2008) Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model. Clin Exp Immunol 154: 295-304.
21. Wittmann M, Purwar R, Hartmann C, Gutzmer R, Werfel T, (2005) Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 124: 1225-1233.
22. Gangemi S, Merendino RA, Guarneri F, Minciullo PL, DiLorenzo G, et al. (2003) Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations. J Eur Acad Dermatol Venereol 17: 42-46.
23. Wang D, Drenker M, Eiz-Vesper B, Werfel T, Wittmann M, (2008) Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum 58: 3205-3215.
24. Companjen A, van der Wel L, van der Fits L, Laman J, Prens E, (2004) Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions. Eur Cytokine Netw 15: 210-216.
25. Johansen C, Moeller K, Kragballe K, Iversen L, (2007) The activity of caspase-1 is increased in lesional psoriatic epidermis. J Invest Dermatol 127: 2857-2864.
26. Ohta Y, Hamada Y, Katsuoka K, (2001) Expression of IL-18 in psoriasis. Arch Dermatol Res 293: 334-342.
27. Naik SM, Cannon G, Burbach GJ, Singh SR, Swerlick RA, et al. (1999) Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J Invest Dermatol 113: 766-772.
28. Companjen AR, Prens E, Mee JB, Groves RW, (2000) Expression of IL-18 in human keratinocytes. J Invest Dermatol 114: 598-599.
29. Gutzmer R, Langer K, Mommert S, Wittmann M, Kapp A, et al. (2003) Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol 171: 6363-6371.
30. Kampfer H, Muhl H, Manderscheid M, Kalina U, Kauschat D, et al. (2000) Regulation of interleukin-18 (IL-18) expression in keratinocytes (HaCaT): implications for early wound healing. Eur Cytokine Netw 11: 626-633.
31. Esteban DJ, Buller RM, (2004) Identification of residues in an orthopoxvirus interleukin-18 binding protein involved in ligand binding and species specificity. Virology 323: 197-207.
32. Reading PC, Smith GL, (2003) Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol 77: 9960-9968.
33. Xiang Y, Moss B, (1999) IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci U S A 96: 11537-11542.
34. Xiang Y, Moss B, (2003) Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain. J Virol 77: 2623-2630.
35. Lee SJ, Cho YS, Cho MC, Shim JH, Lee KA, et al. (2001) Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells. J Immunol 167: 497-504.
36. Bani-Hani AH, Leslie JA, Asanuma H, Dinarello CA, Campbell MT, et al. (2009) IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int 76: 500-511.
37. Hayashi N, Yoshimoto T, Izuhara K, Matsui K, Tanaka T, et al. (2007) T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proc Natl Acad Sci U S A 104: 14765-14770.
38. Xing SS, Bi XP, Tan HW, Zhang Y, Xing QC, et al. (2010) Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats. Mol Med 16: 465-470.
39. Yu Q, Vazquez R, Khojeini EV, Patel C, Venkataramani R, et al. (2009) IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am J Physiol Heart Circ Physiol 297: H76-85.
40. Kanda N, Shimizu T, Tada Y, Watanabe S, (2007) IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Eur J Immunol 37: 338-350.
41. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, et al. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136.
42. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, et al. (2000) Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci U S A 97: 1190-1195.
43. Muhl H, Kampfer H, Bosmann M, Frank S, Radeke H, et al. (2000) Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 267: 960-963.
44. Iannello A, Boulassel MR, Samarani S, Tremblay C, Toma E, et al. (2010) HIV-1 causes an imbalance in the production of interleukin-18 and its natural antagonist in HIV-infected individuals: implications for enhanced viral replication. J Infect Dis 201: 608-617.
45. Paulukat J, Bosmann M, Nold M, Garkisch S, Kampfer H, et al. (2001) Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol 167: 7038-7043.
46. Moller B, Paulukat J, Nold M, Behrens M, Kukoc-Zivojnov N, et al. (2003) Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes. Rheumatology (Oxford) 42: 442-445.
47. Hurgin V, Novick D, Rubinstein M, (2002) The promoter of IL-18 binding protein: activation by an IFN-gamma-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc Natl Acad Sci U S A 99: 16957-16962.
48. Bachmann M, Paulukat J, Pfeilschifter J, Muhl H, (2009) Molecular mechanisms of IL-18BP regulation in DLD-1 cells: pivotal direct action of the STAT1/GAS axis on the promoter level. J Cell Mol Med 13: 1987-1994.
49. Murray DR, Mummidi S, Valente AJ, Yoshida T, Somanna NK, et al. (2011) beta2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo. J Mol Cell Cardiol 52: 206-218.
50. Kaser A, Novick D, Rubinstein M, Siegmund B, Enrich B, et al. (2002) Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients. Clin Exp Immunol 129: 332-338.
51. Corsini E, Mitjans M, Galbiati V, Lucchi L, Galli CL, et al. (2009) Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol In Vitro 23: 789-796.
52. Dinarello CA, (2007) Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 27: 98-114.
53. Park HJ, Kim JE, Lee JY, Cho BK, Lee WJ, et al. (2004) Increased expression of IL-18 in cutaneous graft-versus-host disease. Immunol Lett 95: 57-61.
54. Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F, (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4: 542-548.
55. Lotito AP, Silva CA, Mello SB, (2007) Interleukin-18 in chronic joint diseases. Autoimmun Rev 6: 253-256.
56. Hu D, Liu X, Chen S, Bao C, (2010) Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients. Clin Rheumatol 29: 717-721.
57. Novick D, Elbirt D, Miller G, Dinarello CA, Rubinstein M, et al. (2010) High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein. J Autoimmun 34: 121-126.
58. Antonopoulos C, Cumberbatch M, Mee JB, Dearman RJ, Wei XQ, et al. (2008) IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis. J Leukoc Biol 83: 361-367.
59. Favilli F, Anzilotti C, Martinelli L, Quattroni P, De Martino S, et al. (2009) IL-18 activity in systemic lupus erythematosus. Ann N Y Acad Sci 1173: 301-309.
60. Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, et al. (2002) Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 22: 331-337.
61. Mallat Z, Heymes C, Corbaz A, Logeart D, Alouani S, et al. (2004) Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J 18: 1752-1754.
62. Ziesche E, Bachmann M, Kleinert H, Pfeilschifter J, Muhl H, (2007) The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells. J Biol Chem 282: 16006-16015.
63. Tak PP, Bacchi M, Bertolino M, (2006) Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur J Drug Metab Pharmacokinet 31: 109-116.
64. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, et al. (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22: 127-147.
65. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, et al. (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11: 1014-1022.
66. Sadik CD, Bachmann M, Pfeilschifter J, Muhl H, (2009) Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA. Nucleic Acids Res 37: 5041-5056.